BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

910 related articles for article (PubMed ID: 23629790)

  • 1. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
    Brunner M; Haueter I; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
    Ferrini W; Ambresin A
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bevacizumab and Ranibizumab for macular edema due to retinal vein occlusions].
    Niederhauser N; Valmaggia C
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):405-8. PubMed ID: 23629792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the morphological and functional retinal changes after dexamethasone intravitreal implant (Ozurdex®) in macular edema due to retinal vein occlusion.
    Parravano M; Oddone F; Boccassini B; Giorno P; Chiaravalloti A; Tedeschi M; Scarinci F; Varano M
    Ophthalmic Res; 2014; 51(3):153-60. PubMed ID: 24642474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
    Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
    Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study).
    Capone A; Singer MA; Dodwell DG; Dreyer RF; Oh KT; Roth DB; Walt JG; Scott LC; Hollander DA
    Retina; 2014 Feb; 34(2):342-51. PubMed ID: 23846381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
    Rouvas A; Petrou P; Ntouraki A; Douvali M; Ladas I; Vergados I
    Retina; 2010 Jun; 30(6):893-902. PubMed ID: 20531142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
    Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
    Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cost-effectiveness study of dexamethasone implants in macular edema].
    Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
    Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
    Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
    Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
    Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
    J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.
    Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P
    Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
    Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
    Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
    Ehlers JP; Decroos FC; Fekrat S
    Retina; 2011 Oct; 31(9):1856-62. PubMed ID: 21659943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.